+987.9%
MRNA vs FHN
+14.6%
+973.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FHN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +1.7% | +11.4% | +14.6% |
| 7D | +20.6% | +2.3% | +18.4% | +22.9% |
| 30D | +27.1% | +1.6% | +25.5% | +29.3% |
| 3M | +353.4% | -8.4% | +361.8% | +335.2% |
| 6M | +446.3% | -2.3% | +448.5% | +401.5% |
| YTD | +776.2% | +1.5% | +774.7% | +666.0% |
| 1Y | +987.9% | +15.0% | +972.9% | +810.4% |
| All | +987.9% | +14.6% | +973.3% | +810.4% |
Cumulative growth
Daily Returns
Daily percentage return beside FHN.
Daily Out/Under-Performance
Portfolio return minus FHN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FHN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FHN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling